MRPL1 Antibody

Code CSB-PA014812GA01HU
Size $600
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
Alternative Names
39S ribosomal protein L1 antibody; 39S ribosomal protein L1, mitochondrial precursor antibody; BM022 antibody; L1mt antibody; mitochondrial antibody; Mitochondrial ribosomal protein L1 antibody; MRP L1 antibody; MRP-L1 antibody; Mrpl1 antibody; RM01_HUMAN antibody
Raised in
Species Reactivity
Human MRPL1
Immunogen Species
Homo sapiens (Human)
Purification Method
Antigen Affinity purified
It differs from different batches. Please contact us to confirm it.
PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
Tested Applications
Troubleshooting and FAQs
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Gene References into Functions
  1. MLRP1 could possibly serve as a candidate gene for alterations associated with asbestos exposure. PMID: 26463840
Subcellular Location
Protein Families
Universal ribosomal protein uL1 family
Database Links

HGNC: 14275

OMIM: 611821

KEGG: hsa:65008

STRING: 9606.ENSP00000315017

UniGene: Hs.532019

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details


II. Contact details


III. Ship To


IV. Bill To